A detailed history of First Foundation Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, First Foundation Advisors holds 8,899 shares of ABBV stock, worth $1.59 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,899
Previous 9,710 8.35%
Holding current value
$1.59 Million
Previous $1.67 Million 5.53%
% of portfolio
0.07%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $132,874 - $161,656
-811 Reduced 8.35%
8,899 $1.76 Million
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $24,147 - $28,198
-156 Reduced 1.58%
9,710 $1.67 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $121,463 - $138,396
760 Added 8.35%
9,866 $1.8 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $818,995 - $922,381
-5,952 Reduced 39.53%
9,106 $1.41 Million
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $145,479 - $168,413
1,089 Added 7.8%
15,058 $2.24 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $124,956 - $155,500
943 Added 7.24%
13,969 $1.88 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $196,669 - $226,494
1,360 Added 11.66%
13,026 $2.08 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $19,086 - $22,890
-138 Reduced 1.17%
11,666 $1.89 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $27,647 - $31,709
206 Added 1.78%
11,804 $1.58 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $235,054 - $298,831
-1,708 Reduced 12.84%
11,598 $1.78 Million
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $174,609 - $216,641
1,323 Added 11.04%
13,306 $2.16 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $40,393 - $51,109
376 Added 3.24%
11,983 $1.62 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $54,583 - $61,960
513 Added 4.62%
11,607 $1.25 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $133,406 - $148,622
1,268 Added 12.9%
11,094 $1.25 Million
Q1 2021

May 18, 2021

SELL
$102.3 - $112.62 $75,702 - $83,338
-740 Reduced 7.0%
9,826 $1.06 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $828,805 - $1.12 Million
-10,297 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $20,962 - $24,602
-244 Reduced 2.31%
10,297 $902,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $208,224 - $278,634
2,838 Added 36.84%
10,541 $1.04 Million
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $99,265 - $150,498
1,539 Added 24.97%
7,703 $587,000
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $361,443 - $452,242
-5,011 Reduced 44.84%
6,164 $546,000
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $3,211 - $3,861
51 Added 0.46%
11,175 $846,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $2,628 - $3,359
40 Added 0.36%
11,124 $809,000
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $3,934 - $4,630
-51 Reduced 0.46%
11,084 $893,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $23,043 - $28,418
296 Added 2.73%
11,135 $1.03 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $61,258 - $68,100
689 Added 6.79%
10,839 $1.03 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $60,601 - $71,705
675 Added 7.12%
10,150 $940,000
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $259,100 - $346,959
-2,816 Reduced 22.91%
9,475 $897,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $37,256 - $40,855
-416 Reduced 3.27%
12,291 $1.19 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $134,670 - $172,016
-1,928 Reduced 13.17%
12,707 $1.13 Million
Q2 2017

Aug 14, 2017

BUY
N/A
14,635
14,635 $1.06 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $317B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Foundation Advisors Portfolio

Follow First Foundation Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Foundation Advisors, based on Form 13F filings with the SEC.

News

Stay updated on First Foundation Advisors with notifications on news.